Genomic Variation Articles & Analysis
11 news found
CD Genomics, a leading provider of genomic research solutions, today announced the launch of its cutting-edge Nanopore sequencing services, marking a significant advancement in DNA and RNA analysis capabilities. ...
CD Genomics is a world-leading genomics services company that continues to innovate in high throughput sequencing services for the genomics industry, as well as genotyping, bioinformatics, microarrays, and more. The company launched its Long Amplicon Analysis Service, intending to help simplify project complexity by eliminating additional ...
Targeted region sequencing is a highly targeted approach that allows researchers to assess genetic variation in specific genomic regions. The ultra-deep sequencing of PCR products (amplicons) facilitates the detection and classification of variants effectively. They enable the true on/off-target mutations of genome editing experimentation to be ...
We have published 10 tools from the GRIDSS module software suite (toolkit) containing tools useful for the detection of genomic rearrangements: GRIDSS tool, a structural variation caller for Illumina sequencing data. It calls variants based on alignment-guided positional de Bruijn graph genome-wide break-end assembly, split read, and read pair ...
CD Genomics is a leading services company committed to providing global customers with the most comprehensive analytic services, including a broad range of microbial genomic solutions to support research and development. ...
A pan-genome approach can provide significant improvements, but it is still suboptimal. ...
(NYSE: A) is sharing its vision for precision medicine this week at the annual meeting of the American Society of Human Genomics. The conference, held in Baltimore, Maryland, is a forum for discussing recent advances in all areas of human genetics. "As new technologies and greater understanding of the causes and pathways of diseases are moving through the research-clinical ...
"The SureSelect exome has been widely adopted in both clinical and translational research, and it has greatly enabled discovery of disease-causing genes," said Jacob Thaysen, president of Agilent's Diagnostics and Genomics Group. "The Human All Exon V6 is an important addition to our strong NGS portfolio for constitutional disease research. ...
With the signing of these two new distributors, BioNano Genomics continues to expand the company's global footprint and provide access to the Irys System for genomics researchers to complete genomes and study structural variation. ...
“Gene variations occur naturally, and may become common in a population if they convey a health benefit,” said Douglas Bell, Ph.D., author on the paper and researcher at the National Institute of Environmental Health Sciences (NIEHS), part of NIH. ...
Multi-omics Capability Researchers can use the new RNA capture kits to combine targeted genome and transcriptome data in a single experiment for "integrated biology" insight into the sample. ...